PCT2

N/A

Report date: 2024/11/07 16:30:16

Base Information

Drug NamePCT2
Drug Alias NamePCT2PCT-2
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsColorectal NeoplasmsEsophageal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPan Cancer T BV
China Registration ClassN/A

Develop Information

Active CompaniesPan Cancer T BV
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsColorectal NeoplasmsEsophageal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A